OBaris

🌟 We are delighted to announce that Prof. Jean-Christoph Leroux has been awarded the Phoenix Pharma Science Award in the Pharmaceutical Technology category for his work at ETH Zürich on the OctoPatch technology and our publication in Science Translational Medicine (https://lnkd.in/dsrfPHJQ). Our sincere thanks to PHOENIX group - Integrated Healthcare Provider and the esteemed jury for recognizing this work! 🎉 The OctoPatch is a simple and painless alternative to injectables. If you'd like to learn more about OctoPatch technology, checkout our homepage or reach out to us directly. We're excited to continue advancing this platform and bring this technology to the patients in need! #PharmaScienceAward #OBaris #OctoPatch #ETHZurich #Innovation #PharmaceuticalTechnology #ScienceTranslationalMedicine #PhoenixGroup #DrugDelivery

🎉 Exciting News! 🎉 Transire Bio has changed its name to OBaris as we are Overcoming Barriers! With the new name, we are thrilled to announce that we have joined the amazing group of #InnoBoosterGRS winners! Huge thanks to Gebert Rüf Stiftung for the support in further advancing our technology! 🚀 👏 Congratulations to all winners - Aerospec, IMAI MedTech, and NovoViz! 🎉 Check out the video to learn more about our projects and how the support from InnoBooster will accelerate our market entry! 🔍 For those interested to know more, the Gebert Rüf Foundation is the largest private science and innovation foundation in Switzerland, famous for its various support programs. Explore more on their website - https://lnkd.in/e86A7tM. 🚀 Calling all new co-founders in Switzerland! If you are in the Venture Kick process (and if you're not, you should be 😊), use the opportunity to apply for InnoBooster after Stage I. Show how a further boost in research & development or design can drive your market entry and business success, and GRF can support you with an additional CHF 150'000 for up to 1.5 years! Don't miss the next application deadline on May 1st!

🎊 Last week brought fantastic news: I have been awarded the Bridge Proof of Concept fellowship! 🎊 With the support of 130.000 CHF, we will continue the development of our proprietary OctoPatch® with Transire Bio and translate the technology to the clinic. Our heartfelt gratitude goes to the SNSF Swiss National Science Foundation (SNSF) and the BRIDGE Programme for their trust and support. Your faith in our vision and efforts is immensely appreciated. A special acknowledgment to Nevena Paunović for her exceptional work at Transire Bio, driving us to this pivotal point. Also, we would like to thank ETH Zürich for hosting us, and to ETH Entrepreneurship for their support throughout this journey. https://lnkd.in/eq-M7jsn